In the traditional Chinese medicine processing plant to do physical work
Release time:
2022-12-13
30 ton of Chinese herbal medicine sounds like a number, and what is written down is an order, but the real thing can fill a large truck with a length of more than 10 meters. With such a large batch of goods, the traditional Chinese medicine processing plant of the municipal pharmaceutical company has completed all the links from the inspection and processing of the original medicinal materials to the loading and delivery of the original medicinal materials in a short period of two weeks, in addition to the overall planning of the relevant responsible person, it is also inseparable from the collaborative help and hard work of other personnel.
Due to the shortage of staff in the processing factory, in order not to affect the delivery time, starting from 9# August 19 , the pharmaceutical company will mobilize other post personnel and arrange four or five people to go to the traditional Chinese medicine processing factory every day to assist in the operation. 21# Early in the morning on the 12th, I passed with several other colleagues. At first, I thought it was very easy to move things, but later I found it was completely different from what I had imagined. The processing quantity of Chinese herbal pieces is large, the intensity is high, and the dust is high. The process of participating in the operation is dirty and tiring. At the end of the day, my back is aching, but I still have a sense of accomplishment when I see the finished products of the car and car.
After this physical work, I also have several experiences: First of all, the working people are the most glorious. We only come to help occasionally, but it is not easy for workers who struggle on the front line to do these physical jobs for many years. Second, doing everything requires skill. Even if you do physical work, you can get twice the result with half the effort by turning brute force into ingenuity and practice makes perfect. Otherwise, it is easy to cause physical injury and affect the overall work efficiency. This also tells us that in the future work, we must have a strong body, and we also need experience and reflection to do our work better. Moreover, unity is strength, and unity is invincible. One person needs30 days to work, two people only need 15 days, if 10 people work together, 3 days can be completed. In our future work, we need a sense of teamwork. Together, we can finish the work efficiently and quickly.
This time I went to the processing plant to help, which made me feel that only by combining practical experience with the work direction can I continue to learn and improve in my work, and combine my own efforts with teamwork to create more Performance and benefits.(Shengda)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31